Articles published by Psycheceutical Bioscience, Inc.
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
February 02, 2023
Via GlobeNewswire
Tickers
BWVI
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
January 10, 2023
Via GlobeNewswire
Tickers
BWVI
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
November 29, 2022
Via GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
October 18, 2022
Via GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
October 04, 2022
Via GlobeNewswire
Tickers
BWVI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.